These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33863903)

  • 1. Genetic perturbation of PU.1 binding and chromatin looping at neutrophil enhancers associates with autoimmune disease.
    Watt S; Vasquez L; Walter K; Mann AL; Kundu K; Chen L; Sims Y; Ecker S; Burden F; Farrow S; Farr B; Iotchkova V; Elding H; Mead D; Tardaguila M; Ponstingl H; Richardson D; Datta A; Flicek P; Clarke L; Downes K; Pastinen T; Fraser P; Frontini M; Javierre BM; Spivakov M; Soranzo N
    Nat Commun; 2021 Apr; 12(1):2298. PubMed ID: 33863903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in immunoglobulin-nucleoprotein complex structure mapped by chromatin immunoprecipitation.
    McDevit DC; Nikolajczyk BS
    Mol Immunol; 2006 Apr; 43(10):1541-8. PubMed ID: 16313959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element.
    Bonadies N; Neururer Ch; Steege A; Vallabhapurapu S; Pabst T; Mueller BU
    Oncogene; 2010 Feb; 29(7):1062-72. PubMed ID: 19966852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.
    Hines R; Sorensen BR; Shea MA; Maury W
    J Virol; 2004 Apr; 78(7):3407-18. PubMed ID: 15016863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease.
    Gjoneska E; Pfenning AR; Mathys H; Quon G; Kundaje A; Tsai LH; Kellis M
    Nature; 2015 Feb; 518(7539):365-9. PubMed ID: 25693568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-step, PU.1-dependent mechanism for developmentally regulated chromatin remodeling and transcription of the c-fms gene.
    Krysinska H; Hoogenkamp M; Ingram R; Wilson N; Tagoh H; Laslo P; Singh H; Bonifer C
    Mol Cell Biol; 2007 Feb; 27(3):878-87. PubMed ID: 17116688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of Elf-1: locus-wide analysis reveals four distinct promoters, a tissue-specific enhancer, control by PU.1 and the importance of Elf-1 downregulation for erythroid maturation.
    Calero-Nieto FJ; Wood AD; Wilson NK; Kinston S; Landry JR; Göttgens B
    Nucleic Acids Res; 2010 Oct; 38(19):6363-74. PubMed ID: 20525788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioneering, chromatin remodeling, and epigenetic constraint in early T-cell gene regulation by SPI1 (PU.1).
    Ungerbäck J; Hosokawa H; Wang X; Strid T; Williams BA; Sigvardsson M; Rothenberg EV
    Genome Res; 2018 Oct; 28(10):1508-1519. PubMed ID: 30171019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer and Transcription Factor Dynamics during Myeloid Differentiation Reveal an Early Differentiation Block in Cebpa null Progenitors.
    Pundhir S; Bratt Lauridsen FK; Schuster MB; Jakobsen JS; Ge Y; Schoof EM; Rapin N; Waage J; Hasemann MS; Porse BT
    Cell Rep; 2018 May; 23(9):2744-2757. PubMed ID: 29847803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis.
    Izawa N; Kurotaki D; Nomura S; Fujita T; Omata Y; Yasui T; Hirose J; Matsumoto T; Saito T; Kadono Y; Okada H; Miyamoto T; Tamura T; Aburatani H; Tanaka S
    J Bone Miner Res; 2019 Jun; 34(6):1143-1154. PubMed ID: 30721543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
    Weigelt K; Carvalho LA; Drexhage RC; Wijkhuijs A; de Wit H; van Beveren NJ; Birkenhäger TK; Bergink V; Drexhage HA
    Brain Behav Immun; 2011 Aug; 25(6):1162-9. PubMed ID: 21421043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation.
    Brugnoli F; Lambertini E; Varin-Blank N; Piva R; Marchisio M; Grassilli S; Miscia S; Capitani S; Bertagnolo V
    Exp Cell Res; 2010 Jan; 316(1):38-47. PubMed ID: 19747912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of the murine Emr1 promoter identifies a novel purine-rich regulatory motif required for high-level gene expression in macrophages.
    O'Reilly D; Addley M; Quinn C; MacFarlane AJ; Gordon S; McKnight AJ; Greaves DR
    Genomics; 2004 Dec; 84(6):1030-40. PubMed ID: 15533720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells.
    Wei F; Zaprazna K; Wang J; Atchison ML
    Mol Cell Biol; 2009 Sep; 29(17):4612-22. PubMed ID: 19564417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PU.1 level-directed chromatin structure remodeling at the Irf8 gene drives dendritic cell commitment.
    Schönheit J; Kuhl C; Gebhardt ML; Klett FF; Riemke P; Scheller M; Huang G; Naumann R; Leutz A; Stocking C; Priller J; Andrade-Navarro MA; Rosenbauer F
    Cell Rep; 2013 May; 3(5):1617-28. PubMed ID: 23623495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperation between PU.1 and CAAT/enhancer-binding protein beta is necessary to induce the expression of the MD-2 gene.
    Tissières P; Araud T; Ochoda A; Drifte G; Dunn-Siegrist I; Pugin J
    J Biol Chem; 2009 Sep; 284(39):26261-72. PubMed ID: 19632992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL.
    Humbert M; Federzoni EA; Britschgi A; Schläfli AM; Valk PJ; Kaufmann T; Haferlach T; Behre G; Simon HU; Torbett BE; Fey MF; Tschan MP
    J Leukoc Biol; 2014 Jan; 95(1):83-93. PubMed ID: 24038216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PU.1 as a chromatin accessibility factor for immunoglobulin genes.
    Marecki S; McCarthy KM; Nikolajczyk BS
    Mol Immunol; 2004 Jan; 40(10):723-31. PubMed ID: 14644098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation.
    Batliner J; Mancarelli MM; Jenal M; Reddy VA; Fey MF; Torbett BE; Tschan MP
    Mol Immunol; 2011 Jan; 48(4):714-9. PubMed ID: 21094529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.